Stockreport

Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights

Telesis Bio, Inc.  (TBIO) 
PDF LEXINGTON, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of [Read more]